NowPatient review
NowPatient is a US-UK telehealth platform offering brand-name GLP-1 weight management access including Mounjaro, Wegovy (injection and oral tablet), and Saxenda.
- Scores never bought
- 497 providers tracked
- Every factor auditable
- Updated July 2026
NowPatient earns a Match Score of 58/100 (grade C) and sits #335 of 497 on our board under the balanced default weighting.
- Semaglutide
- $1,349/mo (brand Wegovy)
- Tirzepatide
- $1,069/mo (brand Mounjaro, promotional rate)
- Coverage
- Coverage not published
- Brand-name
- Yes
- Oral option
- Yes
- Verification
- Not independently listed
Best for: People who want brand-name GLP-1 access without a compounded route.
MatchScript's take: Our #335 pick of 497 — one of the few with a non-injection route, scored on the same six factors as everyone else.
The factor breakdown
NowPatient on the six Match Score factors — the same sub-scores the quiz reweights to your priorities. See the methodology.
Semaglutide from $1,349/mo (brand Wegovy) puts Budget Fit at a below-par 36 — above the budget tiers.
Limited or undisclosed state coverage can slow your start, for a below-par 57 on Speed to Start.
NowPatient adds an oral/sublingual route and brand-name access on top of injectables, for a exceptional 95 on Formulary Match.
Support lands at a solid 83 — solid, standard support.
Flexibility scores a below-par 55 — fewer levers to flex your plan.
Disclosure here is thinner than the top of the board give a below-par 28 on Transparency.
Pricing in context
How NowPatient's monthly price sits against the category median and the cheapest provider we track.
What we like
- Free telehealth consultation — you only pay for the medication
- Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
- One of the few platforms offering Wegovy in both injection and oral pill form
- No compounded options — every drug is FDA-approved brand-name
The caveats
- Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)
- No compounded semaglutide or tirzepatide (usually the cheaper route)
- State availability determined during intake, not shown upfront
- Does not offer Foundayo (orforglipron)
Who it's for — and who should skip it
Choose NowPatient if people who want brand-name GLP-1 access without a compounded route.
Skip it if that doesn't sound like you. A closer fit may be Ascend Medical (Match Score 58) — or take the quiz to see where NowPatient lands for your priorities.
How it compares to CoreAge Rx & the closest scorer
NowPatient against our #1 overall pick and the provider that scores closest to it. Green marks the row leader.
| How it compares | NowPatientthis provider | CoreAge Rxour #1 | Ascend Medicalclosest scorer |
|---|---|---|---|
| Sema price | $1,349/mo (brand Wegovy) | $149/mo | Not disclosed |
| Coverage | Coverage not published | All 50 states | 2 states |
| Formulary | Injectable + oral + brand | Injectable | Injectable |
| Match Score | 58 · C | 91 · A− | 58 · C |
NowPatient, answered
Is NowPatient legit?
NowPatient is a real, operating GLP-1 telehealth program, but we don't find it on the LegitScript registry, so it carries less third-party verification than the certified providers on our board. It dispenses compounded medication, which isn't FDA-approved. Vet the prescriber and pharmacy before you commit.
How much does NowPatient cost?
NowPatient lists compounded semaglutide from $1,349/mo (brand Wegovy) and tirzepatide from $1,069/mo (brand Mounjaro, promotional rate) — above our category median of $179/mo. These are the provider's public figures at our last review (July 2026); confirm on their site, since some teaser tiers step up after month one.
Does NowPatient ship to my state?
NowPatient operates in a limited set of states (Coverage not published). If yours isn't on that list, you'll need a nationwide provider instead.
NowPatient vs CoreAge Rx — which is better?
Both are on our board. NowPatient scores 58/100; CoreAge Rx leads our default ranking at 91/100 for its flat nationwide pricing on both molecules and easy cancellation. NowPatient can still win for you if its strengths match your priorities — best for: People who want brand-name GLP-1 access without a compounded route. Run the quiz to see which comes out ahead for you.
Pricing & state data last verified July 2026 from NowPatient's public site and our master provider matrix. The Match Score and its sub-scores are our editorial judgment per the methodology. Commercial facts only — prices change, so confirm on NowPatient's site. Not medical advice; see our disclosure.
NowPatient earns a Match Score of 58/100 (grade C) and sits #335 of 497 on our board under the balanced default weighting. NowPatient is a US-UK telehealth platform offering brand-name GLP-1 weight management access including Mounjaro, Wegovy (injection and oral tablet), and Saxenda. Best for: People who want brand-name GLP-1 access without a compounded route. If it isn't the right fit, Ascend Medical is a sensible alternative to weigh next.
Compare with other providers
Our next-best picks in default ranking order, then the 24 programs that sit nearest NowPatient on the board.
- #1Match91/ 100CoreAge RxThe best all-around match: nationwide access, both molecules at one flat, no-surprise price, and an easy exit.91/100
- #2Match88/ 100Strut HealthThe only program here carrying both LegitScript and ACHC accreditation, with an oral lozenge route on both molecules at the cheapest entry on this board.88/100
- #3Match86/ 100HealthRXA LegitScript-certified, physician-supervised program with a rare oral GLP-1 tablet alongside injectables — both molecules, transparent no-insurance pricing, and a brand-name path.86/100
- #4Match86/ 100ShedRxA weight-focused program that also offers an oral/sublingual route for the needle-averse.86/100
- #5Match88/ 100Ondra HealthNear rock-bottom pricing on both molecules plus some brand access — a rare budget-and-breadth combo, nationwide.88/100
Compare 24 nearby providersHide them
| Provider | Tirzepatide price | Coverage | Alternatives | Go | ||
|---|---|---|---|---|---|---|
| Obu Health#336 | 58 | $190/mo (starting dose, plus a separate fee, compounded) | $239/mo (starting dose, plus a separate fee, compounded) | Coverage not published | Alternatives | Visit |
| Somira Health#337 | 58 | $190/mo (compounded) | $285/mo (compounded) | Coverage not published | Alternatives | Visit |
| TD Tele-Doc Weight Loss#338 | 58 | Not disclosed | Not disclosed | 2 states | Alternatives | Visit |
| Unique Physique#339 | 58 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Bioverse#340 | 57 | $129/mo (starting dose, compounded) | $399/mo (starting dose, compounded) | Coverage not published | Alternatives | Visit |
| BodyLogicMD#341 | 57 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Call-On-Doc#342 | 57 | Not disclosed | Not disclosed | All 50 states | Alternatives | Visit |
| Elevated Health#343 | 57 | $296/mo (compounded) | $359/mo (compounded) | Coverage not published | Alternatives | Visit |
| Empower Pharmacy#344 | 57 | Not disclosed | Not disclosed | All 50 states | Alternatives | Visit |
| Eve#345 | 57 | $195/mo (compounded) | $195/mo (compounded) | Coverage not published | Alternatives | Visit |
| Hello Alpha#346 | 57 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Heros Health#347 | 57 | $199/mo (compounded) | $199/mo (compounded) | Coverage not published | Alternatives | Visit |
| Joi + Blokes#348 | 57 | $199/mo (promotional rate, quarterly plan, compounded) | $299/mo (quarterly plan, compounded) | Coverage not published | Alternatives | Visit |
| Luma Meds#349 | 57 | $249/mo (compounded) | $299/mo (compounded) | Coverage not published | Alternatives | Visit |
| Peptivo#350 | 57 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Revive Meds#351 | 57 | $369/mo (starting dose, compounded) | $459/mo (starting dose, compounded) | All 50 states | Alternatives | Visit |
| Rewinding RX#352 | 57 | Not disclosed | Not disclosed | All 50 states | Alternatives | Visit |
| Rivas Medical Weight Loss#353 | 57 | Not disclosed | Not disclosed | 3 states | Alternatives | Visit |
| Roboclinic#354 | 57 | $179/mo (12-month plan, compounded) | $299/mo (12-month plan, compounded) | Coverage not published | Alternatives | Visit |
| Signos#355 | 57 | $199/mo (6-month plan, compounded) | $199/mo (starting dose, compounded) | Coverage not published | Alternatives | Visit |
| TeleSlim Clinic#356 | 57 | Not disclosed | Not disclosed | 6 states | Alternatives | Visit |
| Voxy#357 | 57 | $179/mo (compounded) | $299/mo (compounded) | Coverage not published | Alternatives | Visit |
| EOS Health#358 | 56 | $199/mo (compounded) | $289/mo (compounded) | 40 states | Alternatives | Visit |
| Form Health#359 | 56 | $1,350/mo (starting dose, brand-name) | $1,350/mo (starting dose, brand-name) | All 50 states | Alternatives | Visit |